logo
episode-header-image
Aug 2024
2m 17s

Bridging Therapy With Tenecteplase or Al...

AMERICAN ACADEMY OF NEUROLOGY
About this episode

Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the efficacy and safety of both thrombolytics in patients with large ischemic core. 

Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398  

Up next
Yesterday
Primary Progressive Aphasia - Part 1
<p>In the first part of this series, Dr. Rogan Magee provides an introduction to primary progressive aphasia (PPA) and explains its three subtypes. </p> <p>Show citations: </p> <ol> <li>Grossman M, Seeley WW, Boxer AL, et al. Frontotemporal lobar degeneration. <em>Nat Rev Dis Pri ... Show More
2m 8s
Nov 24
Women History Minute - Sylvia Lawry
<p>In this episode of the Neurology Minute, Dr. Nara Miriam Michaelson delves into another women's history minute to discuss Sylvia Lawry. </p> 
5m 18s
Nov 21
Dementia with Lewy Bodies and Parkinson Disease Dementia
<p>Dr. Jason Crowell and Dr. YuHong Fu discuss the importance of differentiating between dementia with Lewy bodies and Parkinson disease dementia. </p> <p>Show citatiion: </p> <p>Fu Y, Halliday GM. Dementia with Lewy bodies and Parkinson disease dementia - the same or different a ... Show More
2m 11s
Recommended Episodes
Aug 18
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed. 
29m 55s
Aug 2024
New Data and New Controversies on Cardiac Monitoring and Anticoagulation
Dr. Dan Ackerman talks with Dr. Luciano A. Sposato about the topic of embolic stroke of undetermined source and the controversies surrounding cardiac monitoring and anticoagulation.  Read the related article in Neurology.  Disclosures can be found at Neurology.org. 
23m 52s
Jun 2025
Ep. 553 Dosimetry University Part II: Understanding Partition and Voxel-Based Approaches with Dr. Tyler Sandow and Dr. Nima Kokabi
BSA, MIRD, or voxel-based dosimetry? Join us for part 2 of Dosimetry University where interventional oncologists Dr. Tyler Sandow, Dr. Nima Kokabi, and Dr. Kavi Krishnasamy explore and debate the critical nuances of a successful Y90 procedure, covering dosing methods, lung shunt ... Show More
1h 1m
Jan 2025
Relationship Between Intermittent Hypoxia, COPD and Comorbidities
Dr. Amy Attaway and Dr. Dan Culver review the emerging relationship between COPD patients who have intermittent hypoxemia and an increase they have in co-morbidities and mortality. They discuss how multiple associative studies suggest that intermittent hypoxemia may impact muscul ... Show More
21m 50s
Jun 2025
Clopidogrel Versus Aspirin For Long-term Maintenance Monotherapy In Patients With High Ischemic Risk After PCI
The SMART-CHOICE 3 trial demonstrated that clopidogrel monotherapy is more effective than aspirin monotherapy in reducing the risk of major adverse cardiac and cerebrovascular events in high-risk patients who completed standard dual antiplatelet therapy (DAPT) following percutane ... Show More
9m 15s
Dec 2024
Transfusion Thresholds in Myocardial Infarction
Dr. Centor discusses transfusion thresholds in persons with myocardial infarction with Drs. Jeffrey Carson and Maria Brooks. 
22m 59s
Oct 30
Persistent Postictal Central Apnea in Focal Seizures
Dr. Katie Krulisky talks with Dr. Stefano Meletti about the incidence and characteristics of postictal central apnea in focal seizures. Read the related article in Neurology®. Disclosures can be found at Neurology.org. 
16m 41s
Apr 2025
Glaucoma Medications and Risk of Uveitis
<p class="MsoNormal">Dr. Edmund Tsui interviews authors Dr. Muhammad Z. Chauhan and Dr. Krishna S. Kishor on the risk of uveitis among patients starting topical glaucoma therapy. From their <em>Ophthalmology Glaucoma</em> article, "<a href= "https://www.ophthalmologyglaucoma.org/ ... Show More
17m 1s
Nov 2020
Covid-19 and comorbidities
A recent meta-analysis by Espinosa and colleagues, “Prevalence of Comorbidities in Patients and Mortality Cases Affected by SARS-CoV2”, found that 42% of patients with Covid-19 had comorbidities. Furthermore, 61% of those with Covid-19 admitted to the Intensive Care Unit had como ... Show More
14m 43s
Jul 2025
Epidemiology and Outcomes in HFimpEF | JACC Deep Dive
In this JACC Deep Dive, Editor-in-Chief Harlan M. Krumholz, MD, SM, discusses a large real-world study by Min et al. examining heart failure with improved ejection fraction (HFimpEF) in over 24,000 patients. The study found that while EF improvement is common (30%), true remissio ... Show More
8m 31s